Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
10.4M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
2.13M
-
Shares change
-
-14.6K
-
Total reported value, excl. options
-
$17.2M
-
Value change
-
+$167K
-
Number of buys
-
20
-
Number of sells
-
-26
-
Price
-
$8.09
Significant Holders of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) as of Q3 2025
53 filings reported holding CRVO - CervoMed Inc. - Common Stock, $0.001 par value as of Q3 2025.
CervoMed Inc. - Common Stock, $0.001 par value (CRVO) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.13M shares
of 10.4M outstanding shares and own 20.55% of the company stock.
Largest 10 shareholders include AWM Investment Company, Inc. (863K shares), MORGAN STANLEY (414K shares), VANGUARD GROUP INC (343K shares), MILLENNIUM MANAGEMENT LLC (71.5K shares), GEODE CAPITAL MANAGEMENT, LLC (64.5K shares), BlackRock, Inc. (48.8K shares), CITADEL ADVISORS LLC (30.5K shares), CITIZENS FINANCIAL GROUP INC/RI (30.5K shares), Perigon Wealth Management, LLC (28.7K shares), and Cetera Investment Advisers (27.4K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.